Apyx Medical Corp 8-K Filing
Ticker: APYX · Form: 8-K · Filed: Dec 12, 2025 · CIK: 719135
| Field | Detail |
|---|---|
| Company | Apyx Medical Corp (APYX) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Apyx Medical Corp (ticker: APYX) to the SEC on Dec 12, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ch registered Common Stock, par value $0.001 per share APYX Nasdaq Global Selec).
How long is this filing?
Apyx Medical Corp's 8-K filing is 2 pages with approximately 554 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 554 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-12-12 16:05:42
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share APYX Nasdaq Global Selec
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex3-1.htm (EX-3.1) — 13KB
- form8-k_001.jpg (GRAPHIC) — 7KB
- 0001493152-25-027481.txt ( ) — 234KB
- apyx-20251208.xsd (EX-101.SCH) — 3KB
- apyx-20251208_lab.xml (EX-101.LAB) — 33KB
- apyx-20251208_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. APYX MEDICAL CORPORATION Date: December 12, 2025 By: /s/ Matthew Hill Name: Matthew Hill Title: Chief Financial Officer, Secretary and Treasurer